Credit: Magneto Guitars NAMM 2025: Magneto will showcase two new guitars at NAMM 2025, with the Sonnet Supreme and the Ruby Bass – its first-ever bass build – given a sneak preview ahead of ...

The FDA recently approved Journavx for treating acute pain. This approval is tremendously important for Vertex Pharmaceuticals. The biotech company has also received other good news over the last ...

Next: Access Our New, Shockingly Simple 'Alert System' RBC Capital Markets says Vertex management is optimistic about the recently approved Alyftrek. They predict that most of the 6,000 patients ...

Vertex has been running a number of trials because if there’s one thing that we can take away from the failed drug development projects of the past, it’s that there are many kinds of pain.

The U.S. Food and Drug Administration approved a new prescription-strength pain reliever from Vertex Pharmaceuticals on Jan. 30, 2025. Journavx is a non-opioid drug that prevents peripheral nerves ...

HOUSTON, January 22, 2025--(BUSINESS WIRE)--Vertex Energy, Inc. ("Vertex" or the "Company"), a leading specialty refiner and marketer of high-quality refined products, together with its affiliates ...

UnitedHealthcare likely to cover Vertex’s pain drug Vertex Pharmaceuticals received FDA approval for a new non-opioid pain drug, marketed as Journavx, and it appears the nation’s largest ...

A growing movement is looking to change that. Right-to-repair advocates want to make items in our homes easier to fix and thus less prone to wind up in a landfill. For many, it’s a matter of ...

Microsoft is expanding Xbox Series X|S console repair options in a bid to promote sustainability and reduced waste. As shared via Xbox Wire on Wednesday, the company is now expanding its ...

Will Kirk, best known for his role on The Repair Shop, has shared details of his big move to Surrey and how it has positively impacted his family life. The furniture restorer, 39, appeared on Alan ...

Vertex Pharma could be close to succeeding in the long-standing quest to find an alternative to potentially addictive opioids for the treatment of pain associated with common medical procedures.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...